JCM
GSK icon

J2 Capital Management’s GSK GSK Stock Holding History

J2 Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$594K Sell
11,338
-1,414
-11% -$74.8K 0.4% 62
2026
Q1 		$704K Sell
12,752
-443
-3% -$24K 0.48% 46
2025
Q4 		$647K Sell
13,195
-431
-3% -$20.1K 0.47% 48
2025
Q3 		$588K Sell
13,626
-156
-1% -$6.09K 0.44% 57
2025
Q2 		$529K Buy
13,782
+99
+0.7% +$3.78K 0.42% 58
2025
Q1 		$530K Sell
13,683
-3,930
-22% -$144K 0.49% 36
2024
Q4 		$596K Buy
+17,613
New +$634K 0.56% 35
2023
Q3 		$604K Buy
16,662
+26
+0.2% +$923 0.76% 28
2023
Q2 		$593K Buy
16,636
+1,548
+10% +$55.5K 0.7% 33
2023
Q1 		$537K Buy
15,088
+521
+4% +$18.2K 0.83% 27
2022
Q4 		$512K Buy
14,567
+558
+4% +$18.6K 0.88% 22
2022
Q3 		$412K Buy
14,009
+9,251
+194% +$351K 0.78% 23
2022
Q2 		$259K Sell
4,758
-1,508
-24% -$83.2K 0.39% 61
2022
Q1 		$341K Sell
6,266
-721
-10% -$39.2K 0.37% 56
2021
Q4 		$385K Buy
+6,987
New +$363K 0.37% 44

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return

J2 Capital Management's GSK Position: Q2 2026 in Review

J2 Capital Management reduced its GSK (GSK) stake by 11% in Q2 2026, selling an estimated $74.8K and leaving 11,338 shares worth $594K. The position accounts for 0.4% of the portfolio, ranked #62.

J2 Capital Management first reported a position in GSK in Q4 2021 and has held it in 15 quarters since. The position peaked at $704K in Q1 2026. 186 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • J2 Capital Management held 11,338 shares of GSK worth $594K as of Q2 2026.
  • J2 Capital Management sold 1,414 GSK shares in Q2 2026, an estimated $74.8K.
  • GSK made up 0.4% of J2 Capital Management's portfolio in Q2 2026, its #62 holding.
  • J2 Capital Management first reported a position in GSK in Q4 2021 and has held it in 15 quarters since.
  • J2 Capital Management's GSK position peaked at $704K in Q1 2026.
  • 186 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on J2 Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.